FDA Approves AbbVie’s New Rheumatoid Arthritis Drug
Upadacitinib + Methotrexate & Other csDMARDs in RA Patients
Upadacitinib at the FDA
Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector
Upadacitinib Promising for RA Patients
AbbVie’s RA Drug Succeeds in Late Stage Study
Upadacitinib Proves Superiority to Adalimumab in Phase 3 RA Study
Upadacitinib Receives Breakthrough Designation, Abatacept Use Expands in Australia & More